GlassScriptPhysician profile
Matthew Charles Wakefield
NPI 1770537805
$2,723.89
in general payments reported to CMS, 2019-2025
19 companies · $363 in 2025
The $363 reported for 2025 was more than what a typical Surgery provider received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $162 · 2020: $38.15 · 2021: $838 · 2022: $200 · 2023: $635 · 2024: $488 · 2025: $363.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $723 · Consulting Fee: $465 · Travel and Lodging: $299.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $722.60 |
| Consulting Fee | $465.00 |
| Travel and Lodging | $298.50 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bioptics, INC. | $769.09 | 2019-2021 | |
| Endomagnetics LTD | $524.16 | 2023-2024 | Magtrace, Magseed |
| Leica Microsystems INC. | $465.00 | 2023 | Neoprobe |
| Boston Scientific Corporation | $363.13 | 2025 | Spyglass Discover |
| Ethicon US, LLC | $130.88 | 2019-2022 | |
| Medtronic, INC. | $121.75 | 2022-2024 | Ligasure |
| Heron Therapeutics, INC. | $50.93 | 2022 | |
| Smith+Nephew, INC. | $44.39 | 2020-2022 | |
| Asensus Surgical, INC. | $38.61 | 2019 | |
| Organogenesis INC. | $30.90 | 2024 | Puraply Am |
| Takeda Pharmaceuticals U.S.A., INC. | $28.01 | 2021 | |
| Innocoll Pharmaceuticals Limited | $26.84 | 2021 | |
| Rti Surgical, INC | $24.86 | 2023 | |
| Merck Sharp & Dohme LLC | $24.42 | 2022 | |
| Aroa Biosurgery Incorporated | $20.31 | 2022 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $17.39 | 2020 | |
| Osiris Therapeutics INC. | $15.30 | 2019 | |
| Cardinal Health 414 LLC | $14.83 | 2019 | |
| Shire North American Group INC | $13.09 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Matthew Wakefield listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.